In breast and ovarian cancers, the TNF-α secreted by malignant cells potently induces CCL2/MCP-1 expression, with nearly a twofold increase upon TNF-α stimulation compared with its inhibition (94, 95). This evidence concerns the gene CCL2 and ovarian cancer.